Solventum (MEX:SOLV) Capex-to-Operating-Income : 0.72 (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Solventum Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Solventum's Capital Expenditure for the three months ended in Mar. 2025 was MXN-2,229.94 Mil. Its Operating Income for the three months ended in Mar. 2025 was MXN3,109.65 Mil.

Hence, Solventum's Capex-to-Operating-Income for the three months ended in Mar. 2025 was 0.72.

Solventum Capex-to-Operating-Income Historical Data

The historical data trend for Solventum's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Capex-to-Operating-Income Chart

Solventum Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Capex-to-Operating-Income

0.19

0.15

0.17

0.37

Solventum Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Capex-to-Operating-Income	Get a 7-Day Free Trial							0.27	0.24	0.34	0.93	0.72

Competitive Comparison of Solventum's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Solventum's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solventum's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solventum's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Solventum's Capex-to-Operating-Income falls into.

Save Embed

;

Save Embed

;

Solventum Capex-to-Operating-Income Calculation

Solventum's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-7925.166)	/	21606.505
	=	0.37

Solventum's Capex-to-Operating-Income for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-2229.944)	/	3109.646
	=	0.72

Solventum (MEX:SOLV) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Solventum Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Solventum's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Solventum Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (MEX:SOLV) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

SOLV:USA KB7:Germany

Address

2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144

Website

https://www.solventum.com/en-us/home

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.